PATENT CLAIM ANALYSIS

Application Number: 15962776
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "186100"]

Abstract:
Embodiments of the invention provide a cell immunological assay kit used for evaluating the efficacy of a vaccine on the aspect of cell immunology and a method for storing the cell immunological assay kit. Some embodiments of the invention comprise a MHC-restricted viral antigenic peptide. Further, in some embodiments, the kit may use a vaccine research database of clinical trials and samples which are utilized in the therapeutic and conduct comprehensive testing on immune cells secrete cytokines by flow cytometry to establish a cellular immunology evaluation system. The kit may have a good storage stability and, in particular embodiments, the kit may provide a stability that maintains more than 90% of a material stored therein over a year or more.

Claim (Index 3):
The cell immunological assay kit of  claim 1 , wherein the virus is the hepatitis B virus.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.67532
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10206155', '15007160', '13622965', '14978329', '10532081']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7343365192600024
- 35 USC 102 Novelty (BERT): 0.5387950268971287
- Combined Prediction Score: 0.714782370023715
- Mean Citation Score: 333.7363660000001
- Max Citation Score: 359.90454
- Similarity Product: 252.4682505031085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test